These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6262017)

  • 21. Rous sarcoma virus.
    Svoboda J
    Intervirology; 1986; 26(1-2):1-60. PubMed ID: 2437068
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on recombination in heterologous crosses of Rous sarcoma virus.
    Balduzzi PC; Christensen JR; Notter MF
    J Gen Virol; 1980 Sep; 50(1):173-8. PubMed ID: 6255082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic recombination in Rous sarcoma virus: the genesis of recombinants and lack of evidence for linkage between pol, env and src genes in three factor crosses.
    Wyke JA; Beamand JA
    J Gen Virol; 1979 May; 43(2):349-64. PubMed ID: 90114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ; Marx M; Calothy G; Blair DG
    Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective effect of Rous sarcoma virus src gene expression on contractile protein synthesis in chick embryo myotubes.
    West CM; Boettiger D
    Cancer Res; 1983 May; 43(5):2042-6. PubMed ID: 6299537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of transformed focus morphology in chicken cell cultures infected with Rous sarcoma virus.
    Diglio CA; Dougherty RM
    J Gen Virol; 1977 Sep; 36(3):413-27. PubMed ID: 199692
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reversibility of malignant transformation as affected by the oncogenic virus SV40. II. The characteristics of virus-induced revertant clones].
    Raevskaia GB; Varshaver NB; Shapiro NI
    Genetika; 1987 Dec; 23(12):2196-203. PubMed ID: 2831111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nucleotide sequence of env gene of duck-cells adapted Rous sarcoma virus.
    Zubak SV; Rynditch AV; Kashuba VI; Kavsan VM; Hlozanek I
    Nucleic Acids Res; 1989 Aug; 17(15):6389. PubMed ID: 2549513
    [No Abstract]   [Full Text] [Related]  

  • 29. The src gene product of transformed and morphologically reverted ASV-infected mammalian cells.
    Collett MS; Brugge JS; Erikson RL; Lau AF; Krzyzek RA; Faras AJ
    Nature; 1979 Sep; 281(5728):195-8. PubMed ID: 225672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Env gene of new transformation-defective Rous sarcoma virus variant.
    Zubak SV; Kashuba VI; Kavsan VM; Rynditch AV; Svoboda J; Hlozanek I
    Nucleic Acids Res; 1990 Oct; 18(19):5895. PubMed ID: 2170950
    [No Abstract]   [Full Text] [Related]  

  • 31. A sequence homologous to Rous sarcoma virus v-src Is on human chromosome 20.
    Sakaguchi AY; Naylor SL; Shows TB
    Prog Nucleic Acid Res Mol Biol; 1983; 29():279-83. PubMed ID: 6320292
    [No Abstract]   [Full Text] [Related]  

  • 32. SUMMARY FINDINGS ON THE RAT KARYOTYPE AND ON CHROMOSOMAL CHARACTERISTICS OF RAT TUMOURS INDUCED BY ROUS SARCOMA VIRUS IN VITRO.
    VRBA M; DONNER L
    Neoplasma; 1965; 12():265-84. PubMed ID: 14342401
    [No Abstract]   [Full Text] [Related]  

  • 33. Specific chromosome changes associated with viral transformation of rat glial cells.
    Kano-Tanaka K; Tanaka T
    Int J Cancer; 1982 Oct; 30(4):495-501. PubMed ID: 7141743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Karyotype evolution in a transformed rat cerebral endothelial cell line.
    Tyrkus M; Diglio CA; Gohle N
    Int J Cancer; 1983 Oct; 32(4):485-90. PubMed ID: 6311760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chromosomal evolution of a clone of human cells transformed by Rous sarcoma virus].
    Boué JG; Boué A; Montagnier L; Vigier P
    C R Acad Hebd Seances Acad Sci D; 1968 Jan; 266(2):178-81. PubMed ID: 4297077
    [No Abstract]   [Full Text] [Related]  

  • 36. Karyological analysis of Rous sarcoma virus-producing rat-kangaroo cell lines.
    Donner L; Sainerová H; Svoboda J
    Cytogenet Cell Genet; 1973; 12(2):117-27. PubMed ID: 4351264
    [No Abstract]   [Full Text] [Related]  

  • 37. MMC-E cells--origin and changes in karyotype accompanying malignant transformation.
    Nyström M; Knuutila S; Rapp UR; Keski-Oja J
    Cancer Genet Cytogenet; 1985 Feb; 15(3-4):243-51. PubMed ID: 3971317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative chromosome analysis of primary and metastatic Rous sarcomas in rats.
    Mitelman F
    Hereditas; 1972; 70(1):1-14. PubMed ID: 4376139
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitation in the evaluation of cell substrates for viral vaccine production.
    Parks WP; Hubbell ES
    Adv Exp Med Biol; 1979; 118():23-33. PubMed ID: 495268
    [No Abstract]   [Full Text] [Related]  

  • 40. Chromosomes of the murine leukemia virus indicator cell line XC.
    Nelson-Rees WA
    Chromosoma; 1970; 31(1):51-60. PubMed ID: 4321325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.